** In the United States, USGI Medical’s devices have been cleared by the FDA for approximation of soft tissue in minimally invasive gastroenterology procedures. The use of USGI’s devices to treat obesity (including the POSE procedure) is currently under FDA Investigation. USGI Medical also has a CE Mark Indication for the use of its devices to treat obesity in those patients with a BMI of 30-40.
Results and patient experience may vary. Travel and accommodations for the video shoot provided by USGI Medical.